HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Koebnick, C. Articles by Leitzmann, C. Search for Related Content PubMed PubMed Citation Articles by Koebnick, C. Articles by Leitzmann, C. Related Collections General Clinical Chemistry Nutrition Hematology

Longitudinal Concentrations of Vitamin B₁₂ and Vitamin B₁₂-binding Proteins during Uncomplicated Pregnancy

¹ Institute of Nutritional Science, University of Giessen, D-35392 Giessen, Germany.

² German Institute of Human Nutrition, D-14558 Bergholz-Rehbrücke, Germany.

³ Department of Epidemiology, Maastricht University, 6200 MD Maastricht, The Netherlands.

⁴ Department of Haematology, Imperial College School of Medicine, St. Mary’s Campus, London W2 1PG, United Kingdom.

⁵ Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen-Nuremberg, D-91054 Erlangen, Germany.

⁶ Federal Research Centre for Nutrition, D-76131 Karlsruhe, Germany.

⁷ Department of Clinical Chemistry, University Hospital Rotterdam, 3015 GD Rotterdam, The Netherlands.

^aAddress correspondence to this author at: German Institute of Human Nutrition, Arthur-Scheunert-Allee 114-116, D-14558 Bergholz-Rehbrücke, Germany. Fax 49-33200-88662; e-mail koebnick{at}mail.dife.de.

	Abstract

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Background: Because reference values for vitamin B₁₂ concentrations and vitamin B₁₂-binding capacities for pregnant women have not been established, the reference values for nonpregnant women are often applied to assess vitamin B₁₂ status. The aim of the present study was to describe ranges of biochemical indices of vitamin B₁₂ status, including red blood cell (RBC) vitamin B₁₂, saturated and unsaturated cobalamin-binding proteins, and binding capacities in all trimesters of uncomplicated pregnancy.

Methods: A total of 39 healthy pregnant women with long-term daily intake of vitamin B₁₂ >2.6 µg/day and uncomplicated pregnancies participated in the study throughout their pregnancies. RBCs and serum vitamin B₁₂, holo-haptocorrin, unsaturated cobalamin-binding proteins, unsaturated and total vitamin B₁₂-binding capacities, total homocysteine (tHcy), and RBC count were assessed in weeks 9–12, 20–22, and 36–38 of gestation.

Results: Significant changes in vitamin B₁₂ status occurred in the course of pregnancy. Serum vitamin B₁₂ concentrations and percentage of saturation of vitamin B₁₂-binding proteins decreased steadily throughout pregnancy. In the third trimester, 35% of the participants had serum vitamin B₁₂ concentrations <150 pmol/L and 68.6% had <15% saturation of total vitamin B₁₂-binding capacities, but no women had RBC vitamin B₁₂ concentrations <148 pmol/L. However, the decrease in these indices was not associated with reduced hemoglobin concentrations or RBC count or with increased tHcy concentrations.

Conclusions: Our findings suggest that the reference values for vitamin B₁₂ status in nonpregnant women may not be applicable to pregnant women.

	Introduction

Top Abstract Introduction Subjects and Methods Results Discussion References

 
One of the biochemical functions of cobalamin (vitamin B₁₂) in mammals is to maintain normal folate metabolism, which is essential for cell multiplication during pregnancy. Because maternal vitamin B₁₂ stores in women eating a mixed diet are 3000 µg and the vitamin B₁₂ requirement of the fetus is 50 µg, it may be assumed that the event of a single pregnancy has minimal impact on maternal stores (1). On the other hand, vitamin B₁₂ deficiency, defined as low serum vitamin B₁₂ concentrations, occurs in 10–28% of uncomplicated pregnancies (2).

At present little information is available regarding the normal changes in vitamin B₁₂ metabolism and concentrations of cobalamin-binding proteins during pregnancy (3). Moreover, much of the reported information (4)(5)(6) was collected before the availability of assays for measuring the biologically active form of vitamin B₁₂. No reference values are available for most biochemical indices of vitamin B₁₂ status in pregnant women, and often the reference values for nonpregnant individuals are used to assess their vitamin B₁₂ status. To our knowledge, no longitudinal studies have been performed to validate the applicability of these reference values for pregnant women.

The aim of the present study was to obtain longitudinal information on the biochemical indices of vitamin B₁₂ status throughout pregnancy, especially erythrocyte and serum vitamin B₁₂, holo-haptocorrin, unsaturated cobalamin-binding proteins, unsaturated vitamin B₁₂-binding capacity (UBBC), ¹ and total vitamin B₁₂-binding capacity (TBBC) as well as other associated indices, such as total homocysteine (tHcy). In addition, the consequences of decreasing blood concentrations on associated hematologic indices were investigated. The values presented may be used as reference intervals for cobalamin-binding proteins and cobalamin-binding capacities for healthy pregnant women.

	Subjects and Methods

Top Abstract Introduction Subjects and Methods Results Discussion References

 
study design, participants, and dietary assessment
The study was designed as a prospective longitudinal study throughout pregnancy. Healthy pregnant volunteers (n = 39) entered the study and were followed until delivery. Information on dietary intake and blood samples were collected in the first, second, and third trimesters of gestation (weeks 9–12, 20–22, and 36–38). The study was approved by the Ethics Committee of the Division of Human Medicine, University of Giessen, Germany. All participants gave informed consent.

Descriptions of the design, the recruitment methods, and the conduction of the study have been published in detail elsewhere (7). Briefly, the participants were apparently healthy adults. High-risk and twin pregnancies were excluded. A food frequency list was used to assess dietary habits. Interested women eating an average Western diet that corresponded with the average German population, as defined in the results of the German National Consumption Study, were selected by a priori defined selection criteria. Their diet consisted of >300 g of meat and 105 g of meat products per week. Because of missing laboratory data or relocation and birth of the child before the last blood sampling date, the calculation of ratios of vitamin B₁₂ concentrations in the third to the first trimester is based on a subgroup of 29 pregnant women.

Linked to the blood sampling, a 4-day food record, including categories of 152 food items with given portion sizes estimated by typical household measures, was maintained three times throughout the pregnancy by all participants (8). The calculation of food-derived cobalamin intake was based on the German Food Code and Nutrition Data Base BLS II.3 (9). Folate and cobalamin concentrations in multivitamin-fortified juices were taken from producers’ data. In addition, the intake of food supplements and medication during the record period were registered.

analytical methods
Venous blood was drawn after an overnight fast and immediately stored at 4–7 °C. The analyses of hemoglobin (Hb), and red blood cell (RBC) indices [mean corpuscular volume (MCV) and RBC count] were performed on a Coulter Counter STKS (Beckman Coulter). Between-run CVs (n = 10) were 0.8% for Hb, 0.6% for MCV, and 1.1% for RBC count. Plasma and serum were separated from blood cells within 2 h of venipuncture and stored frozen (-18 °C) until assayed. Serum ferritin concentrations were analyzed by the Enzymun^® assay for ferritin (Roche Diagnostics GmbH); the between-run CV was 5.4% (n = 8; mean concentration, 30 µg/L).

For analysis of RBC vitamin B₁₂, a 20% erythrocyte solution was prepared immediately according to the method of Tisman et al. (10) and was stored frozen until analysis within 6–12 months. Vitamin B₁₂ concentrations in the red cell extracts were determined using the Ciba Corning Magic no-boil radioassay (Ciba Corning Diagnostics Corp.); the between-run CV (n = 10; mean concentration, 362 pmol/L) was 10%. Serum vitamin B₁₂ concentrations were analyzed by the IMx cobalamin assay (Abbot Diagnostics Division), which incorporates microparticles coated with porcine intrinsic factor to bind cobalamin.

Holo-haptocorrin was analyzed by a modification of the method recommended by Das et al. (11) as described by Wickramasinghe and Fida (12). Briefly, a slurry containing synthetic amorphous precipitated silica (Sipernet 283 LS; PQ Corporation) in distilled water was prepared and stored at 4 °C. Holo-transcobalamin was absorbed by adding silica to the serum, vortex-mixing the mixture, and letting it stand for 10 min. The mixture was centrifuged, and the supernatant fluid was assayed for vitamin B₁₂ using the IMx cobalamin assay. The value obtained represents the holo-haptocorrin concentration. The between-run CVs were was 5.1% (n = 10; mean concentration, 303 pmol/L for serum vitamin B₁₂) and 5.4% (n = 15; mean concentration, 138 pmol/L) for holo-haptocorrin. UBBC and unsaturated cobalamin-binding proteins were determined according to the methods of Gottlieb et al. (13) and Jacob and Herbert (14). Radioactive vitamin B₁₂ labeled with ⁵⁷Co was added to the samples. After adsorption of free vitamin B₁₂ to charcoal, total UBBC was measured with the Gamma Master 1277 (LKB Wallac). Microfine silica (Quso G35) was used to separate apo-transcobalamin from apo-haptocorrin. The unsaturated haptocorrin binding capacity was analyzed, and the unsaturated transcobalamin binding capacity was calculated by subtracting the unsaturated haptocorrin binding capacity from UBBC. The between-run CVs (n = 20) were 6.5% for UBBC (mean concentration, 1100 pmol/L), 3% for apo-haptocorrin (mean concentration, 154 pmol/L), and 7.4% for apo-transcobalamin (mean concentration, 952 mol/L).

RBC and plasma folate concentrations were determined with a chemiluminescent competitive protein-binding assay (ACS Folate Assay; Ciba Corning Diagnostics GmbH). The between-run CV was 3.9% (n = 15; mean concentration, 412 nmol/L) for RBC folate and 4.1% (n = 13; mean concentration, 16.4 nmol/L) for plasma folate. The tHcy concentration was measured in plasma according to the methods of Ubbink et al. (15) and Araki and Sako (16). For quantification, the samples were analyzed without and with the addition of a standard amount of tHcy; the average response factors for the added tHcy were used to calculate the concentration of endogenous tHcy. Recoveries in individual samples deviating >10% from the mean were rejected, and the measurement was repeated. The between-run CV (n = 20) for tHcy was 4% at a mean concentration of 8.3 µmol/L. Blood smears were prepared on glass slides and stained by the Pappenheim method (17)(18). Segmentation of neutrophil granulocytes was counted twice from two different blood smears of each woman. The blood smears were subjected to a lobe count (100 nuclei) according to the method of Bung et al. (19). Intraindividual counts that deviated >20% were counted two additional times; the mean value of all four counts was used for data analysis. The CV (n = 9; mean, 2.9 lobes) was 14%.

statistical analysis
Blood concentrations are presented as arithmetic or geometric means and their 95% confidence intervals. Basic characteristics of participants [e.g., age, body mass index (BMI), and parity] and dietary intake are given as the arithmetic mean ± SD. The relationship between intake of vitamin B₁₂ and vitamin B₁₂ concentrations in blood was described by Pearson correlation coefficients. Low serum B₁₂ concentrations were defined as values <150 pmol/L based on Metz et al. (20). All analyses were repeated using cutoff values of 200 and 250 pmol/L. Low RBC vitamin B₁₂ concentrations were defined as values <148 pmol/L based on Herbert (21). In addition, for the RBC vitamin B₁₂ concentrations, a cutoff of 133 pmol/L, based on the results obtained by Tisman et al. (10), was used. Low haptocorrin saturation and TBBC were defined as <20% and <15%, respectively, based on Herbert (21). Folate deficiency was defined as RBC folate concentrations <320 nmol/L (22).

Plasma folate, serum vitamin B₁₂, apo-haptocorrin, and neutrophil segmentation index were log-transformed to normalize the data. To test the effect of stage of pregnancy (first, second, and third trimester) on biochemical indices during pregnancy, generalized estimating equations were used. Generalized estimating equation models allow appropriate analysis of longitudinal data with repeated measurement and missing values. The effect of potentially confounding variables (i.e., maternal age, BMI, parity, and use of oral contraceptives) was tested. All two-way interactions were tested, but no interactions with P <0.15 were found. On the basis of the results of these preliminary analyses, final models included maternal age as the only confounding variable. All analyses were performed using SAS 8.2 (SAS Institute Inc.).

	Results

Top Abstract Introduction Subjects and Methods Results Discussion References

 
dietary intake and other characteristics of the study population
The mean age of the participating pregnant volunteers was 29.1 ± 3.6 years, and the mean BMI before pregnancy was 23.1 ± 4.7 kg/m². The mean parity was 2.0 ± 1.1, and 41% of the participants were primiparous. Four women had more than two previous deliveries, and 12 women took oral vitamin B₁₂ supplements. None of the pregnant women had a twin pregnancy. Eighteen women had taken oral contraceptives within the past 12 months preceding pregnancy. The analysis of covariance showed no effect of BMI, parity, use of oral contraceptives, or cobalamin intake on biochemical indices of vitamin B₁₂ status. The exclusion of women who had more than two previous deliveries and who took oral vitamin B₁₂ supplements did not significantly change any of the reported results.

The mean intake of dietary vitamin B₁₂ from first to third trimester was 5.6 ± 2.0 µg/day. None of the participants had an average vitamin B₁₂ intake below the Recommended Dietary Allowance (RDA) of 2.6 µg/day at any time during pregnancy (22). The intake of vitamin B₁₂ did not correlate with vitamin B₁₂ concentrations in blood. The mean intake of dietary folate from first to third trimester was 273 ± 53 µg/day. Seventeen women (44%) took folate supplements during the current pregnancy. Folate deficiency was observed in 14 women (36%).

rbc and serum vitamin b₁₂ concentrations
RBC and serum vitamin B₁₂ concentrations are shown in Table 1 . The ratios of selected concentrations of the third relative to the first trimester are shown in Table 2 . Serum vitamin B₁₂ concentrations decreased steadily throughout pregnancy. Only one woman showed low serum vitamin B₁₂ concentrations (<150 pmol/L) in the first trimester of pregnancy.

Throughout pregnancy, 3 women (8%) in the second and 12 women (35%) in third trimester developed low serum vitamin B₁₂ concentrations. In contrast, RBC vitamin B₁₂ concentrations increased significantly during this period. Low RBC vitamin B₁₂ concentrations (<148 pmol/L) were observed in four women in the first trimester and in one woman in the second trimester; RBC vitamin B₁₂ concentrations <133 pmol/L were observed in two woman in the first trimester and in one women in the second trimester. No woman with low serum vitamin B₁₂ concentrations simultaneously showed low RBC vitamin B₁₂ concentrations (<148 pmol/L). Similar to the serum vitamin B₁₂ concentrations, a steady decrease in holo-haptocorrin concentrations was observed.

Serum vitamin B₁₂ concentrations and holo-haptocorrin decreased with increasing maternal age (P = 0.041 and 0.035, respectively). No differences between primiparous and nonprimiparous women were observed. No interactions between maternal age and the decreases in serum vitamin B₁₂ and holo-haptocorrin concentrations between first and third trimester were observed, implying that the degree of decrease was not modified by maternal age.

concentrations of cobalamin-binding proteins and vitamin b₁₂-binding capacities
The UBBC and TBBC of the serum increased steadily during pregnancy. TBBC, which also depends on decreasing serum vitamin B₁₂ concentrations, increased less. In the third trimester, 68.6% of women had a TBBC saturation <15%. Whereas the apo-transcobalamin changed only marginally during pregnancy, apo-haptocorrin increased sharply. Consequently, the ratio of apo-transcobalamin and apo-haptocorrin also changed significantly.

consequences of low vitamin b₁₂ concentrations
Most of the indicators of vitamin B₁₂ status in the present study, including Hb, MCV, RBC count, neutrophil segmentation, and plasma and RBC folate concentrations, as well as tHcy concentrations changed significantly during pregnancy. However, results of an analysis of variance showed that changes in any of the above indicators were not affected by vitamin B₁₂ status, but by folate deficiency (data not shown). After adjustment for RBC folate as a predictor for folate status, no differences were observed for tHcy concentrations and neutrophil segmentation between women with low vs normal serum vitamin B₁₂ concentrations in the second and third trimesters. After adjustment for serum ferritin concentrations as a predictor for iron status, no differences were observed for Hb, MCV, and RBC count between women with low vs normal serum vitamin B₁₂ concentrations in the second and third trimesters. In addition, no difference was observed in plasma and RBC folate. Different cutoff values for serum vitamin B₁₂ were used to define low serum vitamin B₁₂ concentrations: <150, <200, and 250 pmol/L.

In the second and third trimesters, women with low (<15%) and normal TBBC saturation did not differ with respect to any of the above indicators of vitamin B₁₂ status.

	Discussion

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Although recent studies have shown that vitamin B₁₂ deficiency can occur during pregnancy, only limited information is available regarding normal changes in the vitamin B₁₂-binding capacities and saturation of the cobalamin-binding proteins during pregnancy (4)(5). Moreover, for most of the biochemical indices of vitamin B₁₂ status, no reference values are available for pregnant women throughout pregnancy.

The aim of the study was to monitor vitamin B₁₂ status throughout uncomplicated pregnancies in women with an adequate vitamin B₁₂ intake. The average intake of food-derived vitamin B₁₂ by the participants was more than twice the RDA, and none of the participants had an average vitamin intake below the RDA for pregnant women (2.6 µg/day) (22). Vitamin B₁₂ intake was not related to vitamin B₁₂ concentrations in serum. On the basis of these data, adequate vitamin B₁₂ intake of all participants can be assumed.

Nevertheless, in the third trimester almost 35% of the participants had serum vitamin B₁₂ concentrations <150 pmol/L, and 70% had a TBBC saturation <15%. In nonpregnant women, serum vitamin B₁₂ concentrations <150 pmol/L and a TBBC saturation <15% are considered indicative of vitamin B₁₂ deficiency (20)(21)(22)(23). However, in the present study in pregnant women, vitamin B₁₂ concentrations below these reference values in the second and third trimesters did not seem to have any deleterious consequences on Hb concentration, RBC count, or tHcy concentrations. Higher cutoff points for serum vitamin B₁₂ concentrations did not alter the results. Similar observations were made by Pardo et al. (24). These results suggest that reference values for nonpregnant women are not suitable for assessing vitamin B₁₂ status during pregnancy, implying the need for reference values related to specific stages of pregnancy.

The present study provides longitudinal values for most biochemical indices of vitamin B₁₂ status, which may be interpreted as preliminary reference values for healthy women during pregnancy. Because more than one-third of the participants (36%) showed signs of folate deficiency, the presented blood indices affected by both vitamin B₁₂ and folate are not suitable as indicators of vitamin B₁₂ deficiency.

Unsaturated concentrations of cobalamin-binding proteins showed a steady increase over the course of the pregnancies. It may be noted that this finding differs from the results of Fernandes-Costa and Metz (4), who observed a moderate decrease in apo-transcobalamin concentrations between the first and second trimesters, followed by a strong increase near delivery. However, the apo-transcobalamin concentrations reported by these authors may be of limited value because they used chicken serum as a competitive binder for the cobalamin assay.

Unsaturated apo-haptocorrin concentrations increased markedly after the second trimester, confirming the results of other studies (4)(5). At present, the role of increased apo-haptocorrin during pregnancy in human serum is not known. In rabbits, only small amounts of injected holo-haptocorrin were transferred to the placenta, and haptocorrin seems to play a minor role for the supply of the fetus (25). Because evidence in the literature suggests a role of haptocorrin in scavenging nonphysiologic vitamin B₁₂ analogs, it was suggested that haptocorrin may be important to protect the fetus from these potentially harmful compounds (26)(27).

In conclusion, the present study indicates that reference values established for nonpregnant women are not suitable for assessing vitamin B₁₂ status in pregnant women. Furthermore, our results suggest that the observed changes in concentrations of cobalamin-binding proteins reflect physiologic changes during pregnancy rather than vitamin B₁₂ deficiency. Further studies are needed to confirm the observed changes in cobalamin-binding proteins during pregnancy and their physiologic implications.

	Acknowledgments

 
We gratefully acknowledge the financial support of the Eden Foundation (Bad Soden, Germany). We also thank the women who participated in the study.

	Footnotes

 
¹ Nonstandard abbreviations: UBBC, unsaturated vitamin B₁₂-binding capacity; TBBC, total vitamin B₁₂-binding capacity; tHcy, total homocysteine; Hb, hemoglobin; RBC, red blood cell; MCV, mean corpuscular volume; BMI, body mass index; and RDA, Recommended Dietary Allowance.

	References

Top Abstract Introduction Subjects and Methods Results Discussion References

 

1. Chanarin I. The megaloblastic anemias, 2nd ed 1979:783pp Blackwell Scientific Publications London. .
2. Shojania AM. Folic acid and vitamin B₁₂ deficiency in pregnancy and in the neonatal period. Clin Perinatol 1984;11:433-459.[Web of Science][Medline] [Order article via Infotrieve]
3. Allen LH. Vitamin B₁₂ metabolism and status during pregnancy, lactation and infancy. Adv Exp Med Biol 1994;352:173-186.[Medline] [Order article via Infotrieve]
4. Fernandes-Costa F, Metz J. Levels of transcobalamins I, II, and III during pregnancy and in cord blood. Am J Clin Nutr 1982;35:87-94.[Abstract/Free Full Text]
5. Bloomfield FJ, Scott JM, Somerville JJ, Weir DG. Levels in normal, pathological, and foetal sera of the three transcobalamins. Ir J Med Sci 1973;142:51-57.
6. Ghosh K, Mohanty D, Rana KS, Hassan SW, Garewal G, Das KC. Plasma transcobalamins in haematological disorders. Folia Haematol Int Mag Klin Morphol Blutforsch 1986;113:766-775.
7. Koebnick C, Heins UA, Hoffmann I, Dagnelie PC, Leitzmann C. Folate status during pregnancy in women is improved by long-term high vegetable intake compared with the average Western diet. J Nutr 2001;131:733-739.[Abstract/Free Full Text]
8. Hoffmann I, Kohl M, Groeneveld M, Leitzmann C. Development and validation of a new instrument to measure food intake. Am J Clin Nutr 1994;59:284S.
9. . Federal Institute for Health Protection of Consumers and Veterinary Medicine. The German Food Code and Nutrient Data Base (BLS II.3): conception, structure and documentation of the data base blsdat 1999:45pp BgVV Publications Berlin, Germany. .
10. Tisman G, Vu T, Amin J, Luszko G, Brenner M, Ramos M, et al. Measurement of red blood cell-vitamin B₁₂: a study of the correlation between intracellular B₁₂ content and concentrations of plasma holotranscobalamin II. Am J Hematol 1993;43:226-229.[Web of Science][Medline] [Order article via Infotrieve]
11. Das KC, Manusselis C, Herbert V. Determination of vitamin B₁₂ (cobalamin) in serum and erythrocytes by radioassay, and of holo-transcobalamin II (holo-TC II) and holo-haptocorrin (holo-TC I and III) in serum by adsorbing holo-TC II on microfine silicea. J Nutr Biochem 1991;2:455-464.
12. Wickramasinghe SN, Fida S. Correlations between holo-transcobalamin II, holo-haptocorrin, and total B₁₂ in serum samples from healthy subjects and patients. J Clin Pathol 1993;46:537-539.[Abstract/Free Full Text]
13. Gottlieb C, Lau KS, Wasserman LR, Herbert V. Rapid charcoal assay for intrinsic factor (IF), gastric juice unsaturated B₁₂ binding capacity, antibody to IF, and serum unsaturated B₁₂ binding capacity. Blood 1965;25:875-884.[Abstract/Free Full Text]
14. Jacob E, Herbert V. Measurement of unsaturated "granulocyte-related" (TC I and TC III) and "liver-related" (TC II) B₁₂ binders by instant batch separation using a microfine precipitate of silica (QUSO G32). J Lab Clin Med 1975;86:505-512.[Web of Science][Medline] [Order article via Infotrieve]
15. Ubbink JB, Vermaak WJ, Bissbort SH. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-446.[Web of Science][Medline] [Order article via Infotrieve]
16. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.[Web of Science][Medline] [Order article via Infotrieve]
17. Ruter A, Gunzer U. Differentiation of granulocytes in Pappenheim stained blood cell smears using standardized cytophotometric analysis. Blut 1984;48:307-320.[Web of Science][Medline] [Order article via Infotrieve]
18. Tolle A, Schaal E, Jahnke HD. [Comparative studies of the differentiation of Pappenheim-Wright stained blood smears in the diagnosis of leukosis]. Zentralbl Veterinarmed [B] 1966;13:62-67.[Medline] [Order article via Infotrieve]
19. Bung P, Stein C, Prinz R, Pietrzik K, Schlebusch H, Bauer O, et al. Folic acid supply in pregnancy—results of a prospective longitudinal study. Geburtshilfe Frauenheilkd 1993;53:92-99.[Medline] [Order article via Infotrieve]
20. Metz J, McGrath K, Bennett M, Hyland K, Bottiglieri T. Biochemical indices of vitamin B₁₂ nutrition in pregnant patients with subnormal serum vitamin B₁₂ levels. Am J Hematol 1995;48:251-255.[Web of Science][Medline] [Order article via Infotrieve]
21. Herbert V. Staging vitamin B₁₂ (cobalamin) status in vegetarians. Am J Clin Nutr 1994;59:1213S-1222S.[Abstract/Free Full Text]
22. . Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B₆, folate, vitamin B₁₂, pantothenic acid, biotin and choline 1998:564pp National Academy Press Washington, DC. .
23. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990;76:871-881.[Abstract/Free Full Text]
24. Pardo J, Peled Y, Bar J, Hod M, Sela BA, Rafael ZB, et al. Evaluation of low serum vitamin B₁₂ in the non-anaemic pregnant patient. Hum Reprod 2000;15:224-226.[Abstract/Free Full Text]
25. Fernandes-Costa F, Metz J. Transplacental transport in the rabbit of vitamin B₁₂ bound to human transcobalamin I, II and III. Br J Haematol 1979;43:625-630.[Web of Science][Medline] [Order article via Infotrieve]
26. Kolhouse JF, Allen RH. Absorption, plasma transport, and cellular retention of cobalamin analogues in the rabbit. Evidence for the existence of multiple mechanisms that prevent the absorption and tissue dissemination of naturally occurring cobalamin analogues. J Clin Invest 1977;60:1381-1392.
27. Kolhouse JF, Kondo H, Allen NC, Podell E, Allen RH. Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin. N Engl J Med 1978;299:785-792.[Abstract]

The following articles in journals at HighWire Press have cited this article:

				A. L. Morkbak*, A.-M. Hvas, N. Milman, and E. Nexo Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum Haematologica, December 1, 2007; 92(12): 1711 - 1712. [Abstract] [Full Text] [PDF]

				M. M. Murphy, A. M. Molloy, P. M. Ueland, J. D. Fernandez-Ballart, J. Schneede, V. Arija, and J. M. Scott Longitudinal Study of the Effect of Pregnancy on Maternal and Fetal Cobalamin Status in Healthy Women and Their Offspring J. Nutr., August 1, 2007; 137(8): 1863 - 1867. [Abstract] [Full Text] [PDF]

				R. Obeid, A. L. Morkbak, W. Munz, E. Nexo, and W. Herrmann The Cobalamin-Binding Proteins Transcobalamin and Haptocorrin in Maternal and Cord Blood Sera at Birth Clin. Chem., February 1, 2006; 52(2): 263 - 269. [Abstract] [Full Text] [PDF]

				B. Riedel, A.-L. B. Monsen, P. M. Ueland, and J. Schneede Effects of Oral Contraceptives and Hormone Replacement Therapy on Markers of Cobalamin Status Clin. Chem., April 1, 2005; 51(4): 778 - 781. [Full Text] [PDF]

				C. Koebnick, I. Hoffmann, P. C. Dagnelie, U. A. Heins, S. N. Wickramasinghe, I. D. Ratnayaka, S. Gruendel, J. Lindemans, and C. Leitzmann Long-Term Ovo-Lacto Vegetarian Diet Impairs Vitamin B-12 Status in Pregnant Women J. Nutr., December 1, 2004; 134(12): 3319 - 3326. [Abstract] [Full Text] [PDF]

				J.G. Ray and H.J. Blom Vitamin B12 insufficiency and the risk of fetal neural tube defects QJM, April 1, 2003; 96(4): 289 - 295. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Koebnick, C. Articles by Leitzmann, C. Search for Related Content PubMed PubMed Citation Articles by Koebnick, C. Articles by Leitzmann, C. Related Collections General Clinical Chemistry Nutrition Hematology